Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Periluminal expression of a secreted transforming growth factor-β type II receptor inhibits in-stent neointima formation following adenovirus-mediated stent-based intracoronary gene transfer.

Appleby CE, Ranjzad P, Williams PD, Kakar SJ, Driessen A, Tijsma E, Fernandes B, Heagerty AM, Kingston PA.

Hum Gene Ther. 2014 May;25(5):443-51. doi: 10.1089/hum.2013.105. Epub 2014 Mar 24.

PMID:
24483849
3.

Adenovirus-mediated gene transfer of transforming growth factor-beta3, but not transforming growth factor-beta1, inhibits constrictive remodeling and reduces luminal loss after coronary angioplasty.

Kingston PA, Sinha S, Appleby CE, David A, Verakis T, Castro MG, Lowenstein PR, Heagerty AM.

Circulation. 2003 Dec 2;108(22):2819-25. Epub 2003 Nov 24.

4.

Blockade of TGF-β by catheter-based local intravascular gene delivery does not alter the in-stent neointimal response, but enhances inflammation in pig coronary arteries.

Chung IM, Kim J, Pak YK, Jang Y, Yang WI, Han I, Park SJ, Park SW, Huh J, Wight TN, Ueno H.

Int J Cardiol. 2010 Dec 3;145(3):468-75. doi: 10.1016/j.ijcard.2009.11.032. Epub 2010 Jan 6.

5.

Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-beta type II receptor using an infiltrator in porcine coronary arteries: efficacy and complications.

Chung IM, Ueno H, Pak YK, Kim JW, Choi DH, Shin GJ, Yang WI, Jang Ys.

Exp Mol Med. 2002 Sep 30;34(4):299-307. Erratum in: Exp Mol Med.2002 Nov 30;34(5):391..

6.

Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries.

Johnson TW, Wu YX, Herdeg C, Baumbach A, Newby AC, Karsch KR, Oberhoff M.

Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):754-9. Epub 2005 Jan 27.

7.

Tranilast prevents activation of transforming growth factor-beta system, leukocyte accumulation, and neointimal growth in porcine coronary arteries after stenting.

Ward MR, Agrotis A, Kanellakis P, Hall J, Jennings G, Bobik A.

Arterioscler Thromb Vasc Biol. 2002 Jun 1;22(6):940-8.

8.

Long-term effect of stent coating with zedoary essential components on neointimal formation in the porcine coronary artery.

Zhao FH, Liu JG, Wang X, Zhang DW, Wang PL, Zhang L, Du JP, Li XZ, Ma YL, Shi Y, Shi DZ.

Chin J Integr Med. 2013 Oct;19(10):771-6. doi: 10.1007/s11655-013-1596-2. Epub 2013 Oct 4.

PMID:
24092241
9.

Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries.

Sheehy A, Hsu S, Bouchard A, Lema P, Savard C, Guy LG, Tai J, Polyakov I.

Cardiovasc Diabetol. 2012 Jun 21;11:75. doi: 10.1186/1475-2840-11-75.

10.

Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries.

Banai S, Gertz SD, Gavish L, Chorny M, Perez LS, Lazarovichi G, Ianculuvich M, Hoffmann M, Orlowski M, Golomb G, Levitzki A.

Cardiovasc Res. 2004 Oct 1;64(1):165-71.

11.

A pyrrole-imidazole polyamide targeting transforming growth factor-beta1 inhibits restenosis and preserves endothelialization in the injured artery.

Yao EH, Fukuda N, Ueno T, Matsuda H, Nagase H, Matsumoto Y, Sugiyama H, Matsumoto K.

Cardiovasc Res. 2009 Mar 1;81(4):797-804. doi: 10.1093/cvr/cvn355. Epub 2008 Dec 20.

12.

Intracoronary radiation before stent implantation inhibits neointima formation in stented porcine coronary arteries.

Waksman R, Robinson KA, Crocker IR, Gravanis MB, Palmer SJ, Wang C, Cipolla GD, King SB 3rd.

Circulation. 1995 Sep 15;92(6):1383-6.

13.

A randomized multicenter comparison of hybrid sirolimus-eluting stents with bioresorbable polymer versus everolimus-eluting stents with durable polymer in total coronary occlusion: rationale and design of the Primary Stenting of Occluded Native Coronary Arteries IV study.

Teeuwen K, Adriaenssens T, Van den Branden BJ, Henriques JP, Van der Schaaf RJ, Koolen JJ, Vermeersch PH, Bosschaert MA, Tijssen JG, Suttorp MJ.

Trials. 2012 Dec 15;13:240. doi: 10.1186/1745-6215-13-240.

14.

Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs.

Varenne O, Pislaru S, Gillijns H, Van Pelt N, Gerard RD, Zoldhelyi P, Van de Werf F, Collen D, Janssens SP.

Circulation. 1998 Sep 1;98(9):919-26.

15.

Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration.

Ma X, Labinaz M, Goldstein J, Miller H, Keon WJ, Letarte M, O'Brien E.

Arterioscler Thromb Vasc Biol. 2000 Dec;20(12):2546-52.

16.

Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis.

Kong J, Hou J, Ma L, Xing L, Jia H, Liu H, Zhang S, Yu B, Jang IK.

Arch Cardiovasc Dis. 2013 Feb;106(2):79-85. doi: 10.1016/j.acvd.2012.10.004. Epub 2013 Jan 30.

17.

Restenosis following placement of an intracoronary heparin treated tantulum stent in the hyperlipidemic miniature swine model.

Jenkins JS, Webel R, Laughlin MH, Rowland SM, Yoklavich MF, Amann JF, Branson K, Myers PR.

J Invasive Cardiol. 1995 Jul-Aug;7(6):173-82.

PMID:
10155102
18.

Overexpression of a constitutively active protein kinase G mutant reduces neointima formation and in-stent restenosis.

Sinnaeve P, Chiche JD, Gillijns H, Van Pelt N, Wirthlin D, Van De Werf F, Collen D, Bloch KD, Janssens S.

Circulation. 2002 Jun 18;105(24):2911-6.

19.

Chimeric DNA-RNA hammerhead ribozyme targeting transforming growth factor-beta 1 mRNA inhibits neointima formation in rat carotid artery after balloon injury.

Ando H, Fukuda N, Kotani M, Yokoyama Si, Kunimoto S, Matsumoto K, Saito S, Kanmatsuse K, Mugishima H.

Eur J Pharmacol. 2004 Jan 12;483(2-3):207-14.

PMID:
14729108
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk